More on OCS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Oculis Holding (NQ:OCS)
Delayed: 12.19 -0.42 (3.33%)
Prev. Close $12.61  
Open$12.43 
52 Wk High$8.14 
52 Wk Low$6.68 
Day High$12.76 
Day Low$12.11 
P/E 406.33  
EPS$0.03 
Volume304,143 


Jun 25, 2026 04:01 PM Form 6-K Oculis Holding AG For: Jun 25
Jun 11, 2026 06:43 AM H.C. Wainwright Reiterates Buy Rating on Oculis Holding AG (OCS)
Jun 3, 2026 08:37 AM Oculis Holding AG (OCS) PT Lowered to $23 at JPMorgan
Jun 2, 2026 06:16 AM Oculis Holding AG (OCS) PT Lowered to $38 at Baird
Jun 1, 2026 07:17 AM Oculis Holding AG (OCS) PT Lowered to $45 at Guggenheim
Jun 1, 2026 07:12 AM Oculis Holding AG (OCS) PT Lowered to $40 at Stifel After Disappointing Ph3 Results
Jun 1, 2026 07:05 AM Oculis Holding AG (OCS) PT Lowered to $38 at Needham
Jun 1, 2026 06:54 AM Oculis Holding AG (OCS) PT Lowered to $26 at H.C. Wainwright
Jun 1, 2026 06:02 AM Form 6-K Oculis Holding AG For: May 29
May 29, 2026 03:06 PM Oculis fails to meet primary endpoint in diabetic macular edema trials
View All Articles

Entities mentioned with OCS

View All Entities